Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?

J Am Coll Cardiol. 2015 Jan 27;65(3):311-2. doi: 10.1016/j.jacc.2014.09.084.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloid Neuropathies, Familial / diagnosis*
  • Aortic Valve / surgery
  • Cardiac Catheterization
  • Cardiomyopathies / diagnosis*
  • Heart Valve Prosthesis Implantation / methods
  • Humans
  • Myocardium / pathology*
  • Pacemaker, Artificial*

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related